Inorganic nanoparticles for biomedical applications

NanoScience in Biomedicine

Volumn , Issue , 2009, Pages 272-289

  Tan, Mei Chee ^a   Chow, Gan Moog ^a   Ren, Lei ^b   Zhang, Qiqing ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896792084     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-49661-8_11     Document Type: Chapter

References (111)

1. Ahn, E. S., N. J. Gleason, A. Nakahira and J. Y. Ying. Nanostructure processing of hydroxyapatitebased bioceramics, Nano Letters 1: 149 (2001).
2. Alexiou C., et al. Targeting cancer cells: Magnetic nanoparticles as drug carriers. Eur. Biophys. J. 35: 446 (2006).
3. Allen, T. M. Ligand-targeted therapeutics in anticancer therapy. Nature Rev. Cancer 2: 750 (2002).
4. Averitt, R. D., D. Sarkar and N. J. Halas. Plasmon resonance shifts of Au-coated Au2S nanoshells: Insight into multicomponent nanoparticle growth. Phys. Rev. Lett. 78: 4217 (1997).
5. Avnir, D., T. Coradin, O. Lev and J. Livage. Recent bioapplications of sol-gel materials. J. Mater. Chem. 16: 1013 (2006).
6. Babes, L., B. Denizot, G. Tanguy, J. J. Le Jeune and P. Jallet. Synthesis of iron oxide nanoparticles used as MRI contrast agents: A parametric study, J. Colloid Interf. Sci. 212: 474 (1999).
7. Barnard, A. S. Nanohazards: Knowledge is our first defense. Nat. Mat. 5: 245 (2006).
8. Behrens, S., et al. Surface engineering of Co and FeCo nanoparticles for biomedical applications. J. Phys. Condens. Matter 18: 2543 (2006).
9. Ben-Nissan, B. Nanoceramics in biomedical applications. MRS Bulletin 1: 28 (2004).
10. Berry, C. C. and A. S. G. Curtis. Functionalization of magnetic nanoparticles for applications in biomedicine. J. Physics D 36: R198 (2003).
11. Brannon-Peppas, L., and J. O. Blanchette. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Del. Rev. 56: 1649 (2004).
12. Brinker, C. J. and G. W. Sherrer. Sol-gel Science, Academic Press, New York (1990).
13. Bruce, I. J. and T. Sen. Surface modification of magnetic nanoparticles with alkoxysilanes and their application in magnetic bioseparations. Langmuir 21: 7029 (2005).
14. Caruso, F. Nanoengineering of particle surfaces. Adv. Mater. 13: 11 (2002).
15. Chan, W. C. W. Bionanotechnology Progress and Advances. Biol. Blood Marrow Transplant. 12: 87 (2006).
16. Chatterjee, J., Y. Haik and C. J. Chen. Size dependent magnetic properties of iron oxide nanoparticles. J. Magnetism Mag. Mater. 257: 113 (2003).
17. Chavanpatil, M. D., A. Khdair and J. Panyam. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J Nanosci. Nanotech. 6: 2651 (2006).
18. Chow, G. M., M. C. Tan, L. Ren and J. Y. Ying. NIR-sensitive nanoparticles. US patent application pending. Publication Number 2006099146 (2006).
19. Coradin, T. and J. Livage. Aqueous silicates in biological sol-gel applications: New perspective for old precursors. Acct. Chem. Res. 40: 819 (2007).
20. Davey, R. J., J. Garside. From Molecules to Crystallizers. Oxford University Press, Oxford, England (2000).
21. Dolmans, D. E. J. G. J., D. Fukumura and R. K. Jain. Timeline: Photodynamic therapy for cancer. Nat. Rev. Cancer 3: 380 (2003).
22. Frangioni, J. V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7: 626 (2003).
23. Frimpong, R. A., S. Fraser and J. Z. Hilt. Synthesis and temperature response analysis of magnetic-hydrogel nanocomposites. J. Biomed Mater. Res. A 80: 1 (2007).
24. Gadre, Y. S. and P. I. Gouma. Biodoped ceramics: Synthesis, properties and applications. J. Ame. Ceram. Soc. 89: 2987 (2006).
25. Gould, P. Nanomagnetism shows in vivo potential. Nanotoday 1: 34 (2006).
26. Green, D. L., J. S. Lin, Y. Lam, M. Z. C. Hu, D. W. Schaefer and M. T. Harris. Size, volume fraction, and nucleation of Stober silica nanoparticles. J. Colloid Interf. Sci. 266: 346 (2003).
27. Gupta, A. K. and M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26: 3995 (2005).
28. Hasirci, V., E. Vrana, P. Zorlutuna, A. Ndreu, P. Yilgor, F. B. Basmanav and E. Aydin. Nanobiomaterials: A review of the existing science and technology, and new approaches. J. Biomater. Sci. Polymer Edn. 17: 1241 (2006).
29. Hayden, M. E. and U. O. Häfeli. 'Magnetic bandages' for targeted delivery of therapeutic agents. J. Phys.: Condens. Matter 18: S2877 (2006).
30. Hilger, A., N. Cüppers, M. Tenfelde and U. Kreibig. Surface and interface effects in the optical properties of silver nanoparticles. Eur. Phys. J. D. 10: 115 (2000).
31. Hirsch, L. R. et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100: 13,549 (2003).
32. Hirsch, L. R., A. M. Gobin, A. R. Lowery, F. Tam, R. A. Drezek, N. J. Halas and J. L. West. Metal nanoshells. Annals Biomed. Engin. 34: 15 (2006).
33. Hirsch, L. R., J. B. Jackson, A. Lee, N. J. Halas and J. L. West. A whole blood immunoassay using gold nanoshells. Anal. Chem. 75: 2377 (2003).
34. Holm, B. A., et al. Nanotechnology in biomedical applications. Mol. Cryst. Liq. Cryst. 374: 589 (2002).
35. Hong, R., N. O. Fischer, T. Emrick and V. M. Rotello. Surface PEGylation and ligand exchange chemistry of FePt nanoparticles for biological applications. Chem. Mater. 17: 4617 (2005).
36. Hood, E. Nanotechnology: Looking as we leap. Enviro. Health Persp. 112: A741 (2004).
37. Hou, Q., P. A. De Bank and K. M. Shakesheff. Injectable scaffolds for tissue regeneration. J. Mater. Chem. 14: 1915 (2004).
38. Huang, X. L., B. Zhang, L. Ren, S. F. Ye, L. P. Sun, Q. Q. Zhang, M. C. Tan and G. M. Chow. In vivo toxic studies and biodistribution of NIR-Sensitive Au-Au2S nanoparticles as potential drug delivery carriers. Submitted. Huber, D. L. Synthesis, properties, and applications of iron nanoparticles. Small 1: 482 (2005).
39. Hughes, G. A., Nanostructure-mediated drug delivery. Nanomed.: Nanotech., Biol. Med. 1: 22 (2005).
40. Hyeon, T. Chemical synthesis of magnetic nanoparticles. Chem. Comm. 927 (2003).
41. Hyeon, T., S. S. Lee, J. Park, Y. Chung and H. B. Na. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size selection process. J. Am. Chem. Soc. 123: 12,798 (2001).
42. Itokazu, M., T. Sugiyama, T. Ohno, E. Wada and Y. Katagiri. Development of porous apatite ceramic for local delivery of chemotherapeutic agents. J. Biomed. Mater Res. 39: 536 (1998).
43. Jaspreet, K. V., M. K. Reddy, V. D. Labhasetwar, Nanosystems in drug targeting: opportunities and challenges. Curr. Nanosci. 1: 47 (2005).
44. Jin, S. and K. Ye. Nanoparticle-mediated drug delivery and gene therapy. Biotechnol Prog 23: 32 (2007).
45. Jurgons, R., C. Seliger, A. Hilpert, L. Trahms, S. Odenbach and C. Alexiou, Drug loaded magnetic nanoparticles for cancer therapy, J. Phys.: Condens. Matter 18: S2893 (2006).
46. Foster, K. A., M. Yazdanian and K. L. Audus. Microparticulate uptake mechanisms of in vitro cell culture models of the respiratory epithelium. J Pharmacy Pharmacology 53: 57 (2001).
47. Kagan, V. E., H. Bayir and A. A. Shvedova. Nanomedicine and nanotoxicology: Two sides of the same coin. Nanomedicine 1: 313 (2005).
48. Kirchner, C., et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles, Nano Lett. 5: 331 (2005).
49. Kittel C. Introduction to Solid State Physics. 8th Ed. Hoboken: John Wiley & Sons (2005).
50. Klein, L. C. Processing of nanostructured sol-gel materials. In: A. S. Edelstein and R. C. Cammarata. eds. Nanomaterials: Synthesis, Properties and Applications. Institute of Physics Publishing, Bristol and Philadelphia, pp. 147 (1996).
51. Kossovsky, N., et al. Surface-modified nanocrystalline ceramics for drug delivery applications. Biomaterials 15: 1201 (1994).
52. Kost, J., R. Langer. Responsive polymeric delivery systems. Adv. Drug Del. Rev. 46: 125 (2001).
53. Kreibig, U. and M. Vollmer. Optical Properties of Metal Clusters. Berlin: Springer (1995).
54. Kumta, P. N., C. Sfeir, D. H. Lee, D. Olton and D. Choi. Nanostructured calcium phosphates for biomedical applications: Novel synthesis and characterization. Acta Biomat. 1: 65 (2005).
55. Lin, X. M. and C. S. Samia. Synthesis, assembly and physical properties of magnetic nanoparticles. J. Magnetism Magnetic Mater. 305: 100 (2006).
56. Link, S. and M. A. El-Sayed. Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int. Rev. Phys. Chem. 19: 409 (2000).
57. Link, S. and M. A. El-Sayed. Size and temperature dependence of the plasmon absorption of colloidal gold. J. Phys. Chem. B 103: 4212 (1999).
58. Linnert, T., P. Mulvaney and A. Henglein. Surface chemistry of colloidal silver: Surface plasmon damping by chemisorbed I-, SH-, and C6H5S-. J. Phys. Chem. 97: 679 (1993).
59. Livage, J., M. Henry and C. Sanchez. Sol-gel chemistry of transition metal oxides. Prog. Solid State Chem. 18: 259 (1988).
60. Loo, C., A. Lowery, N. Halas, J. West and R. Drezek. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5: 709 (2005).
61. Love, J. C., L. A. Estroff, J. K. Kriebel, R. G. Nuzzo and G. M. Whitesides. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem. Rev. 105: 1103 (2005).
62. Lübbe, A. S., C. Bergemann, J. Brock and D. G. McClure. Physiological aspects in magnetic drug-targeting. J. Magnetism Magnetic Mater. 194: 149 (1999).
63. Luo, D. and W. M. Saltzman. Thinking of silica. Gene therapy 13: 585 (2006).
64. Luo, D. Nanotechnology and DNA Delivery. MRS Bulletin 30: 654 (2005).
65. Moghimi, S. M., A. C. Hunter and J. C. Murray. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53: 283 (2001).
66. Neuberger, T., B. Schopf, H. Hormann, M. Hofmann and B. von Rechenberg. Superparamagnetic nanoparticles for biomedical applications; Possibilities and limitations of a new drug delivery system. J. Magnetism and Magnetic Mater 293: 483 (2005).
67. Niederberger, M. and G. Garnweitner. Organic reaction pathways in the nonaqueous synthesis of metal oxide nanoparticles. Chem. Eur. J. 12: 7282 (2006).
68. Niemz, M. H. Laser-Tissue Interactions: Fundamentals and Applications. Springer-Verlag: Berlin (2002).
69. Oldenburg, S. J., R. D. Averitt, S. L. Westcott and N. J. Halas. Nanoengineering of optical resonances. Chem. Phys. Lett. 288: 243 (1998).
70. Olton, D., J. Li, M. E. Wilson, T. Rogers, J. Close, L. Huang, P. N. Kumta and C. Sfeir. Nanostructured calcium phosphates for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 28: 1267 (2007).
71. Oskam, G. Metal oxide nanoparticles: Synthesis, characterization and application. J. Sol-Gel Sci. Technol. 37: 161 (2006).
72. Panyam, J. and V. Labhasetwar. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Del. Rev. 55: 329 (2003).
73. Park, J., et al. Ultra-large-scale synthesis of monodisperse nanocrystals. Nature Mater. 3: 891 (2004).
74. Persson, B. N. J. Polarizability of small spherical metal particles influence of the matrix environment. Surf. Sci. 281: 153 (1993).
75. Petrak, K., Nanotechnology and site-targeted drug delivery. J. Biomater. Sci. Polymer Edn. 17: 1209 (2006).
76. Pinchuk, A., U. Kreibig and A. Hilger. Optical properties of metallic nanoparticles: Influence of interface effects and interband transitions. Surf. Sci. 557: 269 (2004).
77. Pitkethly, M. J. Nanomaterials-the driving force. NanoToday 12: 20 (2004).
78. Prasad, P. N., Nanophotonics. Hoboken, NJ: John Wiley & Sons (2004).
79. Qiang, Y., J. Antony, A. Sharma, J. Nutting, D. Sikes and D. Meyer. Iron/iron oxide core-shell nanoclusters for biomedical applications. J. Nanoparticle Res 8: 489 (2006).
80. Ren, L. and G. M. Chow. Synthesis of NIR-sensitive Au-Au2S nanocolloids for drug delivery. Mater. Sci. Eng. C 23: 113 (2003).
81. Ren, L., X. L. Huang, B. Zhang, L. P. Sun, Q. Q. Zhang, M. C. Tan and G. M. Chow. Cisplatin loaded Au-Au2S nanoparticles for potential cancer therapy: Cytotoxicity. in vitro Carcinogenicity, and cellular uptake. Submitted. Salgueiriño-Maceira V., R. Caruso and L. M. Liz-Marzán. Coated colloids with tailored optical properties. J. Phys. Chem. B 107: 10,990 (2003).
82. Sato, S., et al. Nanosecond, high-intensity pulsed laser ablation of myocardium tissue at the ultraviolet, visible, and near-infrared wavelengths: In-vitro study. Lasers Surg. Med. 29: 464 (2001).
83. Sayes, C. M., et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 4: 1881 (2004).
84. Sershen, S., J. West. Implantable, polymeric systems for modulated drug delivery. Adv. Drug Del. Rev. 54: 1225 (2002).
85. Sheludko, A. Colloid Chemistry. Elsevier: Amsterdam (1966).
86. Singh, R., et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. USA. 103: 3357 (2006).
87. Stokes, R. J. and D. F. Evans. Fundamentals of Interfacial Engineering. New York: Wiley-VCH (1997).
88. Tan, M. C. NIR-sensitive nanoparticles for targeted drug delivery. PhD Thesis, (2006).
89. Tan, M. C., J. Y. Ying and G. M. Chow. Structure and microstructure of NIR-absorbing Au-Au2S nanoparticles. Submitted.
90. Temenoff, J. S. and A. G. Mikos. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 21: 2405 (2000).
91. Templeton, A. C., W. P. Wuelfing and R. W. Murray. Monolayer-protected cluster molecules. Acc. Chem. Res. 33: 27 (2000).
92. Tirelli, N. (Bio)responsive nanoparticles. Curr. Opin. Coll. Interf. Sci. 11: 210 (2006).
93. Turkevich, J., P. C. Stevenson and J. Hillier. The nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 11: 55 (1951).
94. U. S. Food and Drug Administration. http://www. cfsan. fda. gov/~redbook/red-toca. html, Toxicological Principles for the Safety Assessment of Food Ingredients, 2000.
95. Uchida, A., Y. Shinto, N. Araki and K. Ono. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. J. Orthop. Res. 10: 440 (1992).
96. Vallet-Regi, M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem. Eur. J. 12: 5934 (2006).
97. Vallet-Regi, M. Revisiting ceramics for medical applications. Dalton Trans. 44: 5211 (2006).
98. Vioux, A. Nonhydrolytic sol-gel routes to oxides. Chem. Mater. 9: 2292 (1997).
99. Vogel, A. and V. Venugopalan. Mechanisms of pulsed laser ablation of biological tissues. Chem. Rev. 103: 577 (2003).
100. Waynant, R. W., I. K. Ilev and I. Gannot. Mid-infrared laser applications in medicine and biology. Philos. Trans. R. Soc. Lond. Ser. A-Math Phys. Eng. Sci. 359: 635 (2001).
101. Weissleder, R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19: 316 (2001).
102. West, J. L., N. J. Halas. Applications of nanotechnology to biotechnology. Curr. Opin. Biotech. 11: 215 (2000).
103. West, J. L., N. J. Halas. Engineered nanomaterials for biophotonics applications: Improving sensing, imaging, and therapeutics. Ann. Rev. Biomed. Eng. 5: 285 (2003).
104. Whitesides, G. M. Nanoscience, nanotechnology, and chemistry. Small 1: 172 (2005).
105. Xu, Z. P., Q. H. Zeng, G. Q. Lu and A. B. Yu. Inorganic nanoparticles as carriers for efficient cellular delivery. Chemical Engineering Science 61: 1027 (2006).
106. Yin, H., H. P. Too and G. M. Chow. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 26: 5818 (2005).
107. Yong, T. H., Apatite-polymer composites for the controlled delivery of bone morphogenetic proteins. PhD Thesis. MIT (2005).
108. Yong, T. H., E. A. Hager and J. Y. Ying. Apatite-polymer composite particles for controlled delivery of BMP-2. Singapore-MIT Alliance Symposium Proceedings (2004).
109. Yu, S. and G. M. Chow. Carboxyl group (CO2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications. J. Mater. Chem. 14: 2781 (2004).
110. Zhou, H. S., I. Honma and H. Komiyama. Controlled synthesis and quantum-size effect in gold-coated nanoparticles. Phys. Rev. B 50: 12,052 (1994).
111. Zhu, S. H., et al. Hydroxyapatite nanoparticles as a novel gene carrier. J. Nanoparticle Res. 6: 307 (2004).